The remaining Xocova tablets produced by Shionogi & Co., Lagevrio capsules made by Merck & Co. and Paxlovid pills manufactured by Pfizer Inc., estimated to be worth 300 billion yen ($1.93 billion ...

The oral drug Xocova marks the first home-grown medication, developed by Shionogi & Co., which can be prescribed for patients with mild symptoms, suggesting a stable supply of the tablet will be ...

The findings also indicated that administering antiviral drugs such as PaxlovidPACK and Xocova orally to patients in the acute stage of infection may help to suppress their otherwise lingering ...